Breaking News

Business

Frivolous lawsuit against MMJ.TODAY dismissed

As some of you may be aware, MMJ today’s holding company was recently served with a lawsuit pertaining to the alleged defamation of a certain writer who covers micro-cap stocks trading on the OTC. This writer in particular had frequently written hit pieces on an MMJ company we cover,  called Creative Edge Nutrition (FITX) over the course of a 1 …

Read More »

THE AMBROSE AGENDA – An Indepth Look

THE AMBROSE AGENDA – An Indepth Look The last year for Canadians, ahead of their Federal Election in the fall of 2015, has been one of dismay, disappointment, and quite frankly, down right dirty politics.  What do we mean? MMJ.today has written a number of articles pertaining to the company, CEN Biotech Inc, a company established solely to pursue a …

Read More »

CEN Biotech CEO Funds Company, Forgives $2 Million Debt – Updated

CEN Biotech Inc, a wholly owned Canadian subsidiary of the hotly debated publicly traded company Creative edge nutrition (OTC: FITX) which is actively engaged in seeking a licence to grow marijuana under Canada’s newly formed MMPR, filed it’s quarterly financials last week on the OTC markets. Both the company and it’s CEO, Dr. Bill Chaaban, who is a licensed attorney in both …

Read More »

MMPR Producer Health Check, Organigram

OrganiGram How successful are current licensed producers under Canada’s Medical Marijuana Program? Health Canada seems to have a growing concern under its Marijuana programs and how viable these companies actually are. While it is not my intention to report negative findings of any particular company, I believe it’s important to understand or at least shed some light on Health Canada’s …

Read More »

Potential Criminal Indictment of Stock Basher Matthew Finston – Updated

In light of recent developments surrounding an alleged campaign to destroy the publicly traded company’s share price. CEN Biotech (OTC: FITX), a Canadian subsidiary actively engaged in seeking a licence to grow marijuana under Canada’s newly formed MMPR, has had approximately 100 documented negative and defamatory articles written against the company over the span of just 1 year, almost exclusively (60+) …

Read More »

Distortion and Cyber-terrorism – Canadian Medical Marijuana Company Targeted

Collaboration: from the Latin word collaboratus, a past participle of collaborare “to labor together”, from Latin com- + laborare to labor. In a letter dated January 13th, 2014 from the Licences and Permits Division of Health Canada’s Office of Controlled Substances, CEN Biotechs CEO, Mr. Bill Chaaban is personally thanked for his collaboration with Health Canada through the licensing process …

Read More »

Health Canada Faces Quality Control Issues Under MMPR

Health Canada faces quality control issues in the delivery of product from companies operating under the MMPR (Marijuana for Medical Purposes Regulations). In a recent surprise move by the IIROC, Aphria a publicly traded company, was suspended from trading on March 31, 2015. Aphria trades on the TSX-Venture markets in Canada under the symbol APH.V. The halt resulted from what …

Read More »

Capricious Actions by Health Canada Causing Detrimental Reliance to MMPR Applicants

Capricious Actions by Health Canada Causing Detrimental Reliance to MMPR Applicants Health Canada plays favorites with MMPR Applicants and LPs. Arbitrary behavior towards applicants by Health Canada. Health Canada lacks placement of, or effective adherence to internal SOP’s. Health Canada’s internal system broken. Corrective actions required. Health Canada has demonstrated a clear lack of diligence through capricious actions towards applicants …

Read More »

CEN Biotech Files Application for Judicial Review – UPDATED

UPDATED: CEN Biotech Files Application for Judicial Review and is seeking discovery. Health Canada Has 10 days to oppose Mandamus or issue a license under MMRP CEN Biotech and other applicants treated unfairly CEN Biotech requested to accelerate build out, receiving no license CEN Biotech Inc. has filed application for judicial review through the federal courts in Ontario against the …

Read More »

Work Hard In Silence

“Work hard in silence, and let your success make the noise” is the most apt quote that comes to mind when we consider the patience of investors throughout CEN Biotech’s 90 day Quiet Period, ending shortly on Feb. 17th 2015. In the face of bashers and their misplaced skepticism, CEN Biotech will soon be making another strategicallyok well-timed spin off …

Read More »